These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 21468660)
21. Social and structural determinants of HAART access and adherence among injection drug users. Krüsi A; Wood E; Montaner J; Kerr T Int J Drug Policy; 2010 Jan; 21(1):4-9. PubMed ID: 19747811 [TBL] [Abstract][Full Text] [Related]
22. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence. Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395 [TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of adherence to highly active antiretroviral therapy in patients with HIV infection in China. Wang YY; Jin Y; Chen C; Zheng W; Wang SB; Ungvari GS; Ng CH; Zhang XD; Wang G; Xiang YT AIDS Care; 2019 Aug; 31(8):913-922. PubMed ID: 30554523 [TBL] [Abstract][Full Text] [Related]
24. Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. Nicastri E; Leone S; Angeletti C; Palmisano L; Sarmati L; Chiesi A; Geraci A; Vella S; Narciso P; Corpolongo A; Andreoni M J Antimicrob Chemother; 2007 Oct; 60(4):724-32. PubMed ID: 17715125 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the predictive performance of adherence measures for virologic failure detection in people living with HIV: a systematic review and pairwise meta-analysis. Almeida-Brasil CC; Moodie EEM; Cardoso TS; Nascimento ED; Ceccato MDGB AIDS Care; 2019 Jun; 31(6):647-659. PubMed ID: 30516060 [TBL] [Abstract][Full Text] [Related]
26. Vets, denialists and rememberers: social typologies of patient adherence and non-adherence to HAART from the perspective of HIV care providers. Orchard T; Salters K; Palmer A; Michelow W; Lepik KJ; Hogg R AIDS Care; 2015; 27(6):758-61. PubMed ID: 25635938 [TBL] [Abstract][Full Text] [Related]
27. Long-term trends in adherence to antiretroviral therapy from start of HAART. Cambiano V; Lampe FC; Rodger AJ; Smith CJ; Geretti AM; Lodwick RK; Puradiredja DI; Johnson M; Swaden L; Phillips AN AIDS; 2010 May; 24(8):1153-62. PubMed ID: 20299959 [TBL] [Abstract][Full Text] [Related]
28. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. Nieuwkerk PT; Oort FJ J Acquir Immune Defic Syndr; 2005 Apr; 38(4):445-8. PubMed ID: 15764962 [TBL] [Abstract][Full Text] [Related]
29. Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals. Murri R; Guaraldi G; Lupoli P; Crisafulli R; Marcotullio S; von Schloesser F; Wu AW AIDS Patient Care STDS; 2009 Jan; 23(1):35-9. PubMed ID: 19183079 [TBL] [Abstract][Full Text] [Related]
30. The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study. Cooper V; Horne R; Gellaitry G; Vrijens B; Lange AC; Fisher M; White D J Acquir Immune Defic Syndr; 2010 Mar; 53(3):369-77. PubMed ID: 20087195 [TBL] [Abstract][Full Text] [Related]
31. Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients. Cicconi P; Cozzi-Lepri A; Castagna A; Trecarichi EM; Antinori A; Gatti F; Cassola G; Sighinolfi L; Castelli P; d'Arminio Monforte A; HIV Med; 2010 Feb; 11(2):104-13. PubMed ID: 19732176 [TBL] [Abstract][Full Text] [Related]
33. Alcohol use and antiretroviral adherence: review and meta-analysis. Hendershot CS; Stoner SA; Pantalone DW; Simoni JM J Acquir Immune Defic Syndr; 2009 Oct; 52(2):180-202. PubMed ID: 19668086 [TBL] [Abstract][Full Text] [Related]
34. An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand. Ruanjahn G; Roberts D; Monterosso L AIDS Care; 2010 Dec; 22(12):1555-61. PubMed ID: 20582752 [TBL] [Abstract][Full Text] [Related]
35. Profile of adherence to highly active antiretroviral therapy of patients older than 50 years old. Pardi GR; Nunes AA; Preto R; Canassa PG; Correia D J Acquir Immune Defic Syndr; 2009 Oct; 52(2):301-3. PubMed ID: 20118680 [No Abstract] [Full Text] [Related]
36. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients. Maggiolo F; Ripamonti D; Arici C; Gregis G; Quinzan G; Camacho GA; Ravasio L; Suter F HIV Clin Trials; 2002; 3(5):371-8. PubMed ID: 12407486 [TBL] [Abstract][Full Text] [Related]
37. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization. Cunningham WE; Markson LE; Andersen RM; Crystal SH; Fleishman JA; Golin C; Gifford A; Liu HH; Nakazono TT; Morton S; Bozzette SA; Shapiro MF; Wenger NS J Acquir Immune Defic Syndr; 2000 Oct; 25(2):115-23. PubMed ID: 11103041 [TBL] [Abstract][Full Text] [Related]
38. [Adherence to HAART, quality of life and psychopathological symptoms among HIV/AIDS infected patients]. Margalho R; Pereira M; Ouakinin S; Canavarro MC Acta Med Port; 2011 Dec; 24 Suppl 2():539-48. PubMed ID: 22849945 [TBL] [Abstract][Full Text] [Related]
39. Adherence to antiretroviral therapy for HIV/AIDS in Latin America and the Caribbean: Systematic review and meta-analysis. Costa JM; Torres TS; Coelho LE; Luz PM J Int AIDS Soc; 2018 Jan; 21(1):. PubMed ID: 29356390 [TBL] [Abstract][Full Text] [Related]
40. Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort. Shet A; Kumarasamy N; Poongulali S; Shastri S; Kumar DS; Rewari BB; Arumugam K; Antony J; De Costa A; D'Souza G Curr HIV Res; 2016; 14(1):71-9. PubMed ID: 26303008 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]